Dynamic Technology Lab Private LTD Rocket Pharmaceuticals, Inc. Transaction History

Dynamic Technology Lab Private LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$7.96 - $16.64 $194,287 - $406,149	-24,408 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$13.16 - $23.68 $321,209 - $577,981	24,408 New	24,408 $387,000
Q4 2021 Feb 14, 2022	SELL	$21.52 - $36.02 $369,498 - $618,463	-17,170 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$27.42 - $48.97 $470,801 - $840,814	17,170 New	17,170 $513,000
Q2 2021 Aug 13, 2021	SELL	$39.41 - $47.25 $355,557 - $426,289	-9,022 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$43.34 - $65.91 $391,013 - $594,640	9,022 New	9,022 $400,000

243

94.3M

262K

159K

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $618M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.